www.gsk.com
Open in
urlscan Pro
34.117.83.221
Public Scan
Submitted URL: https://www.gsk.com/
Effective URL: https://www.gsk.com/en-gb/
Submission: On July 18 via manual from US — Scanned from DE
Effective URL: https://www.gsk.com/en-gb/
Submission: On July 18 via manual from US — Scanned from DE
Form analysis
1 forms found in the DOM/en-gb/search/
<form action="/en-gb/search/" class="header-search" id="header-search" tabindex="-1">
<!--?xml version="1.0" encoding="UTF-8"?-->
<svg class="icon-search" width="17px" height="18px" viewBox="0 0 17 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<title>Location</title>
<g id="Symbols" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
<g class="icon-shape" id="Menu_open_1728" transform="translate(-1636.000000, -11.000000)">
<g id="Group" transform="translate(0.000000, 0.072535)">
<g id="Pre_nav" transform="translate(0.000000, 8.122777)">
<g id="Location" transform="translate(1636.000000, 2.877223)">
<path
d="M5.66667918,10.3888889 C3.01064948,10.3888889 0.859997209,8.18514098 0.946994057,5.51004612 C1.02746614,3.03565366 3.03563455,1.02748914 5.51005833,0.947017212 C5.56233601,0.945293193 5.6147463,0.944444444 5.66662613,0.944444444 C8.32268235,0.944285304 10.4733611,3.14821888 10.3863378,5.82331374 C10.3058392,8.29773272 8.29764424,10.3058707 5.82324698,10.3863426 C5.77099583,10.3880667 5.71858553,10.3888889 5.66667918,10.3888889 M17,16.2189701 L10.2853365,9.50555206 C10.2246725,9.4448732 10.142328,9.41076562 10.0565644,9.41076562 L10.0543627,9.41076562 L10.0543627,9.27550071 C10.1411106,9.27550071 10.2220563,9.23390862 10.2745092,9.16476114 C11.0013891,8.20614908 11.4328493,7.01121838 11.4328493,5.71546701 C11.4328752,2.56645943 8.85706496,0.000207183478 5.71577417,0 C5.69316117,0 5.6709108,0 5.64824599,0.000414366955 C2.54565375,0.0366714756 0.0373198565,2.54413541 0.000408595344,5.64598285 C-0.0373315503,8.81746983 2.5442291,11.4307786 5.71644764,11.4307786 L5.71647354,11.4307786 C7.01562042,11.4307527 8.21335847,10.9972472 9.17336209,10.2673139 C9.23853313,10.2177712 9.27570342,10.1397407 9.27570342,10.0579291 L9.41104471,10.0579291 C9.41088929,10.1445059 9.44523619,10.2275865 9.50647003,10.2888869 L16.2188541,17"
id="Fill-1"></path>
</g>
</g>
</g>
</g>
</g>
</svg>
<div class="easy-autocomplete" style=""><input type="search" class="header-search__input js-auto-complete" title="Search" placeholder="Enter a search term..." name="q" id="eac-3270" autocomplete="off">
<div class="easy-autocomplete-container" id="eac-container-eac-3270">
<ul></ul>
</div>
</div>
<a href="" class="header-search__close" aria-label="Close">
<svg class="icon-close">
<use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/assets/img/icon-sprite.svg#icon-close"></use>
</svg>
</a>
<button type="submit" class="screen-reader-only" tabindex="-1"></button>
</form>
Text Content
* Skip to Content * Skip to Search Global Change location Healthcare professionals Healthcare professionals Contact us Contact us Search Location GSK logo linking to the homepage * Behind the science magazine Back to main Behind the science magazine * Behind the science magazine Close menu * Company Back to main Company * Company * Purpose, strategy and culture * Outstanding people Company Outstanding people * Working together * My GSK story * Innovating together 2022 * Innovating together 2021 * GSK at a glance * History and heritage * Board of directors and leadership team * Board information * Governance Company Governance * Committees * Shareholders * Sarbanes-Oxley Act 2002 * Compliance * Policy positions * Codes, standards and reports FEATURED SECTION Our purpose, strategy and culture FEATURED SECTION Outstanding people Close menu * Innovation Back to main Innovation * Innovation * Research and development approach * Pipeline * Therapeutic areas Innovation Therapeutic areas * Infectious diseases * HIV * Respiratory/immunology * Oncology * Opportunity-driven * Technologies * Clinical trials at GSK Innovation Clinical trials at GSK * Provision of unlicensed medicines for unmet medical needs * Data transparency * Diversity in clinical trials * Partnering with GSK Innovation Partnering with GSK * Supported studies * R&D locations SPOTLIGHT ON Behind the science magazine Featured section Partnering with GSK Close menu * Products Back to main Products * Products * Our product areas * Products A-Z SPOTLIGHT ON Innovation FEATURED WEBSITE GSKPro Close menu * Responsibility Back to main Responsibility * Responsibility * Access * Global health and health security Responsibility Global health and health security * Global health * Health security * Using our science for global health * Improving access to healthcare * Environment Responsibility Environment * Climate * Water * Materials and waste * Biodiversity * Diversity, equity and inclusion * Ethical standards Responsibility Ethical standards * Working with third parties * Public policy and patient advocacy * Human rights * Use of animals * Engaging with healthcare professionals * Product governance * Charitable Investments * ESG resources Responsibility ESG resources * ESG reports archive FEATURED SECTION Diversity equity and inclusion SPOTLIGHT ON Our policy positions Close menu * Investors Back to main Investors * Investors * Why invest in GSK? * Quarterly results * Financial reports Investors Financial reports * Annual Report 2022 * Corporate reports archive * Speeches and presentations * Dividend and share price Investors Dividend and share price * GSK share price * Share price calculators (GBp/USD) * Dividend calculators (GBp/USD) * Dividend calendar * Events calendar * Analyst consensus * Shareholder information Investors Shareholder information * Manage your shares * Annual General Meeting * General Meeting * Annual Governance Meeting * Corporate sponsored nominee service * Our ADR programme * Asset reunification - ProSearch * Share scam alert * Privacy notice for ordinary shareholders * FAQs * Stock exchange announcements Investors Stock exchange announcements * London (RNS) * London (RNS) inside information * New York (SEC) * Sign up for announcements * Corporate actions Investors Corporate actions * Consumer Healthcare Demerger * Consumer Healthcare Joint Venture * Agreement to acquire TESARO * Debt investors * Investors contact details SPOTLIGHT ON Press releases SPOTLIGHT ON Our pipeline Close menu * Media Back to main Media * Media * Press releases * Media contacts * Conferences * Media library * Our response to the situation in Ukraine * Our response to COVID-19 * Our social media * RSS feeds FEATURED SECTION Behind the science magazine SPOTLIGHT ON Our response to Covid Close menu * Careers Back to main Careers * Careers * Search jobs * Featured careers Careers Featured careers * A career in Data * Life at GSK Careers Life at GSK * What’s your angle? * Experienced professionals Careers Experienced professionals * Business Operations * Engineering at GSK * Manufacturing and supply * Marketing and sales * Research and development Experienced professionals Research and development * Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS) * Genomic sciences * Technology * Early talent Careers Early talent * Kickstart your career * Apprentice programmes * Work experience, placements and internships * Future leaders graduate programme Early talent Future leaders graduate programme * Business operations * Engineering * Manufacturing Operations, Quality & Logistics * Marketing and sales * Research and development * Technology * Post graduate opportunities * Our global and regional hubs * How we hire Careers How we hire * Frequently asked questions * Fraudulent internet recruitment activities FEATURED SECTION Outstanding people FEATURED SECTION Diversity equity and inclusion Close menu * Healthcare professionals Healthcare professionals * Contact us Contact us INNOVATION INNOVATION DRIVES DISEASE PREVENTION We're uniting science, technology and talent to get ahead of RSV. Discover our innovation story and what getting ahead together means with our updates from the BIO International Convention. Innovation GSK at BIO 2023 RSV 0:30 Close Video OUR STRATEGY WE ARE A GLOBAL BIOPHARMA COMPANY WITH A PURPOSE TO UNITE SCIENCE, TECHNOLOGY AND TALENT TO GET AHEAD OF DISEASE TOGETHER. WE AIM TO POSITIVELY IMPACT THE HEALTH OF 2.5 BILLION PEOPLE BY THE END OF 2030. OUR BOLD AMBITIONS FOR PATIENTS ARE REFLECTED IN COMMITMENTS TO GROWTH AND A STEP-CHANGE IN PERFORMANCE. WE ARE A COMPANY WHERE OUTSTANDING PEOPLE CAN THRIVE. Our R&D focus is on four therapeutic areas: infectious diseases, HIV, respiratory/immunology and oncology Purpose, strategy and culture Why invest in GSK? Infectious diseases 1 in 3 of us will be affected by shingles in our lifetime Go to infectious diseases HIV 38m people in 2021 are living with HIV worldwide Go to HIV Respiratory/Immunology 25yrs of leading research to help people with inflammatory conditions Go to respiratory/immunology Oncology ~10m people died from cancer in 2020, making it a leading cause of death worldwide Go to oncology Behind the science DISCOVER HOW WE'RE GETTING AHEAD ‘THE ROAR I HEAR IS THE NEXT STAGE OF THE ROCKET FIRING’: MAPS TECHNOLOGY AND THE NEW AGE OF VACCINE DEVELOPMENT FRESH INSIGHTS COULD FINALLY HELP US TACKLE RSV ‘I HAD NEVER EXPERIENCED ANYTHING LIKE IT’: THE PAIN, RISKS, AND FIRST SYMPTOMS OF SHINGLES EVERY ADULT SHOULD KNOW AGE-RELATED DECLINE IN IMMUNITY: WHY DOES IT MATTER AND WHAT CAN BE DONE ABOUT IT? ‘WE’RE NOT A WORLD OF MEN – IT'S AS SIMPLE AS THAT’: HOW GENDER DIVERSITY IN CLINICAL TRIALS IMPROVES HEALTH OUTCOMES FOR WOMEN AI AND ML POWER BETTER PREDICTIONS FOR PATIENT IMPACT DIGITAL TWIN: USING ADVANCED TECHNOLOGY TO ACCELERATE VACCINE DEVELOPMENT THE ‘TRIPLEDEMIC’ WILL HIT OLDER PEOPLE HARD THIS WINTER – BUT THERE ARE THINGS WE CAN ALL DO TO REDUCE THE IMPACT Read our magazine Life at GSK HOW WE HELP PEOPLE THRIVE CULTURE At GSK, culture is something we all own. It’s powered by the little things GSK people do every day to help us get ahead of disease together. It drives delivery of our strategy and makes GSK a place people can thrive. Being ambitious for patients, accountable for impact and making sure we always do the right thing is how we deliver for patients, shareholders, and of course the people who work here. The Code Purpose, strategy and culture GROWTH Helping people grow professionally and personally is fundamental to GSK. Because we know when individuals grow, our company grows too. Everyone at GSK is encouraged to drive their development through a blend of on-the-job experiences, plus best-in-class formal and informal learning. Life at GSK DIVERSITY, EQUITY AND INCLUSION We’re dedicated to diversity, equity and inclusion in what we do and how we do it. Because it's the right thing to do and it helps us perform better. That’s why we focus on recognising and making the most of our differences and encourage everyone to bring their authentic selves to work. We make sure everyone gets equal opportunities and we’re fully committed to ensuring our workforce reflects the communities in which we work. Diversity, equity and inclusion WELLBEING We prioritise personal wellbeing so that our people can thrive both in and out of work. We achieve this by fostering a healthy and safe working space for them to succeed and grow. Above all, working at GSK means working with colleagues, friends and managers who support, motivate and care for one another every step of the way. Life at GSK Careers at GSK OUTSTANDING PEOPLE INNOVATING TOGETHER 2022 Meet Euan: using technology in drug discovery INNOVATING TOGETHER 2022 Meet Mugdha: working together to help more patients INNOVATING TOGETHER 2022 Meet Pal: combining the power of genetics and genomics WORKING TOGETHER Meet P.J.: how a life-changing diagnosis changed his career WORKING TOGETHER Meet Jess: advocating for patients WORKING TOGETHER Meet Fiona: improving health and wellbeing through nature View all series POSITIVELY IMPACTING SOCIETY AND THE PLANET * Access * Global health and health security * Environment * Diversity, equity and inclusion * Ethical standards * Product governance 01 / 06 Previous slide Next slide ACCESS We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships. Access GLOBAL HEALTH AND HEALTH SECURITY We are committed to using our science, our partnerships, and the knowledge we’ve gained from addressing the world’s biggest health challenges to improve health globally. Global health and health security ENVIRONMENT We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045. Environment DIVERSITY, EQUITY AND INCLUSION Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team. Diversity, equity and inclusion ETHICAL STANDARDS Our culture guides our people to do the right thing and act on any concerns they have. Ethical standards PRODUCT GOVERNANCE Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together. Product governance IN THE SPOTLIGHT INNOVATION We shared our innovation story and what getting ahead together means at the BIO international convention in Boston, 5-8 June PARTNERS Working with our partners to deliver the next generation of transformational vaccines and medicines MEDIA GSK tops Access to Medicine Index (ATMI) for eighth consecutive time INVESTORS We've published our 2022 Annual Report and ESG Performance Report LONDON 1,332.60 GBp +14.00 SHARE PRICE AT 18 JULY 2023 17:01 Go to calculator NYSE 34.73 USD +0.22 SHARE PRICE AT 18 JULY 2023 12:43 Go to calculator INVESTORS We announced our first quarter 2023 results on Wednesday 26 April View latest results Continue to Company GSK This is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be reached by visiting our location selector. © 2001-2023 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GSK plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom. Modern Slavery Act statement 2022 (PDF - 189.7KB) * GSK websites * Locations selector * GSKPro for healthcare professionals * GSK study register * Supplier website * ViiV Healthcare * Quick links * Behind the science magazine * Company * Innovation * Products * Responsibility * Investors * Media * Careers * Get in touch * Partnerships * Report a possible side effect * GSK Speak up * Follow us on: * facebook * twitter * youtube * linkedin * instagram * rss * Accessibility * Terms of use * Cookie policy * Privacy notice * Sitemap We use cookies GSK values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Others are optional: performance cookies show us how you use our website and features; functional cookies remember your preferences; and advertising cookies help us share relevant content.Cookie Policy * Performance cookies Collect information about your use of our website, e.g. page visits or error messages. This information is aggregated and anonymised and used to improve our website. If you don’t allow these cookies, we won’t know when you have visited our website and won’t be able to monitor its performance * Functional cookies Allow our websites to remember your user name, language preference, or geographic region. This information is used to provide a personalised experience and to make the website easier to use. If you don’t allow these cookies, then some or all features may not function * Advertising cookies Allow us to display advertising we think is relevant to you. We build profiles based on your browsing history, which we share with our advertising partners to show you relevant advertisements on other sites. If you don’t allow these cookies you will still receive advertising, but it will be less relevant Show detail ❮ Show less ❮ Opt out Accept all